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Diseases, National Institutes of Health, Bethesda MarylandABSTRACT Transthyretin (TTR) is a largely b-sheet serum protein responsible for transporting thyroxine and vitamin A. TTR is
found in amyloid deposits of patients with senile systemic amyloidosis. TTR mutants lead to familial amyloidotic polyneuropathy
and familial amyloid cardiomyopathy, with an earlier age of onset. Studies of amyloid fibrils of familial amyloidotic polyneurop-
athy mutant TTR suggest a structure similar to the native state with only a simple opening of a b-strand-loop-strand region
exposing the two main b-sheets of the protein for fibril elongation. However, we find that the wild-type TTR sequence forms
amyloid fibrils that are considerably different from the previously suggested amyloid structure. Using protease digestion with
mass spectrometry, we observe the amyloid core to be primarily composed of the C-terminal region, starting around residue
50. Solid-state NMR measurements prove that TTR differs from other pathological amyloids in not having an in-register parallel
b-sheet architecture. We also find that the TTR amyloid is incapable of binding thyroxine as monitored by either isothermal calo-
rimetry or 1,8-anilinonaphthalene sulfonate competition. Taken together, our experiments are consistent with a significantly
different configuration of the b-sheets compared to the previously suggested structure.INTRODUCTIONSenile systemic amyloidosis (SSA) results from large
amyloid deposits primarily within the heart, but also in the
kidneys, liver, and muscles (1,2). These amyloid deposits
are composed mainly of transthyretin (TTR) (3,4), a serum
protein that transports thyroid hormone (thyroxine, T4) and
vitamin A (5). Mutations within TTR lead to earlier onset
of amyloid diseases: familial amyloidotic polyneuropathy
(FAP) is a consequence of a V30M substitution and familial
amyloid cardiomyopathymainly results from eitherV122I or
L55P mutations (2). TTR is a 55 kDa tetramer folded as
a dimer of dimers (Fig. 1 A). Each monomer contains eight
b-strands located within the 127 amino acid protein as
follows; A (11–19), B (23–36), C (40–49), D (53–55), E
(67–74), F (91–97), G (104–112), and H (114–123) (6,7).
Only a very short a-helix is present from residues 76 to 82
(Fig. 1 B). Within a monomer the strands are arranged into
two sheets consisting of CBEF and DAGH. The C and D
strands fold over the main core region of the protein, with
the D strand followed by a large loop composed of 11 resi-
dues (56–66) (6,7). The dimer is connected though antipar-
allel arrangements of the F and F0 strands and of the H and
H0 strands (note that strands on successive monomers are
denoted with 0, 00, etc.) (Fig. 1 B).
The structure of TTR within the amyloid fibril (the
disease form) has not yet been solved. An early report,
examining cross sections of amyloid material extracted
from patients with FAP by electron microscopy, found the
diameter of the fibrils to be 13 nm with a fourfold symmetry
(8). Each protofilament measured 4 to 5 nm across, arrangedSubmitted August 25, 2011, and accepted for publication October 11, 2011.
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0006-3495/11/11/2485/8 $2.00around a central hollow core (8). Further x-ray fiber diffrac-
tion analysis of the FAP extracted material pointed to
a twisted b-sheet model of amyloid structure (9). The
diffraction pattern revealed an 11.5 nm repeat, which was
interpreted as a repeating unit of 24 b-strands. This led to
a proposed model with six of the native TTR b-strands,
AGH and BEF forming an AGHH0G0A0 and BEFF0E0B0
structure, repeating with a fourfold screw axis (9). The
AGH and BEF strands were assumed to be in the essentially
native arrangement, but with the strand orientation altered to
make them perpendicular to the filament long axis. This
implied that the C and D strands fold away from the two
main b-sheets, opening this interface to allow for elongation
and fibril formation with the B and F strands as the interact-
ing edge strands for one sheet and A and H for the other
(Fig. 1 B). Because FF0 and HH0 are interfaces in the native
dimer, this model suggests that the fibrils can be built from
dimeric building blocks (9). More recent electron paramag-
netic resonance studies, using specific cysteine mutations
and electron spin labels, supported this proposed structure
without the V30M mutation (10,11).
Here, we have studied the amyloid fibrils generated from
wild-type (WT) TTR, and present evidence that it may form
a substantially different structure than what has been
reported with mutated TTR sequences.MATERIALS AND METHODS
Protein expression
Transthyretin-His6 was expressed, labeled, and purified from BL21-
CodonPlus (CD3) RIPL cells as previously described (12). Absorbance
measurements at 280 nm of the eluted fractions from the Ni-NTA column
were used to determinewhich fractions to pool for dialysis. Pooled fractionsdoi: 10.1016/j.bpj.2011.10.009
FIGURE 1 Native TTR three-dimensional structure. (A) TTR exists as
tetramer of identical subunits forming a dimer of dimers. Each monomer
has two different interfaces with two other monomers. The thyroxine (T4)
binding site is indicated on the side of the tetramer along the A, G, H strands.
(B) View of a normal dimer revealing that the monomers dimerize through
antiparallel interactions of F and F0 strands and the H and H0 strands. This
view led to the notion of the C strand to D strand loop opening allowing
for elongation to form the amyloid. This figure was generated using PDB
entry 1F41 (7) and the program Swiss PdbViewer version 4.
2486 Bateman et al.(6 ml) were dialyzed twice against 4 l of 10 mM phosphate pH 8.0, 1 mM
EDTA, 1 mM DTTat 4C. TTR concentration was determined using absor-
bance at 280 nm and an extinction coefficient of 7.76 104 M1 cm1 (13).
For solid-state NMR measurements, TTR samples were prepared with 13C
labeling of backbone carbonyl sites of Ile, Phe, or Tyr residues (1-13C-Ile-
TTR, 1-13C-Phe-TTR, and 1-13C-Tyr-TTR).TTR amyloid fibril generation
TTR at 1 mg/ml in 50 mM sodium acetate pH 4 was incubated without
shaking at 37C for at least six months, conditions identical to those used
by Serag et al. (10,11). Before use, amyloid samples were centrifuged at
12,000  g for 5 min. The supernatant was removed and the fibril pellet
was washed and centrifuged twice with 20 mM phosphate, 150 mM
NaCl, and 0.1% Tween 20 pH 7.2, and then resuspended to desired concen-
trations with 50 mM sodium acetate pH 4.Biophysical Journal 101(10) 2485–2492Protease digestion
In duplicate, 1 mM native TTR or TTR amyloid fibrils were digested in
a total volume of 20 ml in 50 mM ammonium bicarbonate pH 7.8,
100 mM CaCl2 for 24 h. Digestions with 200–20 ng Proteinase K (Invitro-
gen, Carlsbad, CA), 2–200 ng trypsin (Sigma, St. Louis, MO), and 2–200 ng
Chymotrypsin (Sigma) were carried out at 37C, whereas 20C digestion
was used with 2–200 ng Glu-C (Princeton Separations, Adelphia, NJ). To
stop digestions, samples were treated with 5 ml 99% Trifluoro acetic acid.
Samples were lyophilized and either resuspended with loading dye for elec-
trophoresis on NuPAGE Bis-Tris 4–12% gradient gels using NuPAGEMES
running buffer (Invitrogen), or with 5% acetic acid for mass spectrometry
with an HP series 1100 MSD LC/MS. Data analysis was performed using
HP ChemStation Rev. A.05.01 (Hewlett Packard, Palo Alto,CA). Calcu-
lated masses for the peptide fragments were obtained using the FindPept
tool available on the Expasy website (http://web.expasy.org/findpept/),
with the settings [MþH]þ, average and 2 dalton mass tolerance.Electron microscopy
The TTR amyloid fibril suspension was adsorbed to a carbon-coated copper
grid for 3 min, washed briefly with H2O, stained for 3 min with 1% phos-
photungstic acid (Sigma) pH 4.3, blotted, and air dried. The stained samples
were examined with an FEI Morgagni transmission electron microscope
(FEI, Hillsboro, OR) operating at 80 kV.Thioflavin T fluorescence
A fivefold molar excess of Thioflavin T was added to 1 mM TTR samples
or 1 mM bovine serum albumin for 30 min at room temperature before
analysis with a PTI spectrophotometer (PTI, Birmingham, NJ) using
a 1 ml cuvette. Emission spectra were collected from 460 to 560 nm using
450 nm excitation. The area under the peak from 475 to 495 nm was inte-
grated and the mean with standard deviation was plotted for five indepen-
dent experiments.Solid-state NMR
One-dimensional (1D) NMR spectra and 13C-13C dipolar recoupling data,
using the PITHIRDS-CT method (14), were acquired on an InfinityPlus
spectrometer (Varian, Lexington, MA) operating at 9.39 T (100.4 MHz
13C NMR frequency), using a Varian 3.2 mm magic-angle spinning
(MAS) NMR probe. Native TTR samples (1 mg/ml) were dialyzed in 4 l
of water at room temperature for 2 h and lyophilized. Amyloid TTR
samples (1 mg/ml) were washed with water and centrifuged at 5000  g
twice, lyophilized, and packed in thick-wall 3.2 mm diameter MAS rotors.
Samples were rehydrated with 5 ml water. Conditions for PITHIRDS-CT
measurements were as previously described (14), with pulsed spin locking
during detection for improved signal-to-noise (15). MAS frequencies were
20.00 kHz. 1H decoupling fields were 110 kHz. 13C T2 relaxation values for
each carbonyl-labeled sample were measured under PITHIRDS-CT condi-
tions by varying the constant-time recoupling period of the PITHIRDS-CT
sequence while keeping the effective recoupling time equal to zero (14); the
constant-time period was adjusted so that carbonyl signals at zero effective
recoupling time were at least 25% of the signals in a simple 1D spectrum.
Raw PITHIRDS-CT data were corrected as described (12) for the 1.1%
natural abundance 13C at unlabeled carbonyl sites.Isothermal calorimetry
L-Thyroxine sodium salt (T4) (Sigma) was dissolved in 10 mM sodium
phosphate, 100 mM KCl, 1 mM EDTA pH 8.0 to 50 mM, determined
using absorbance at 325 nm and an extinction coefficient of 6.18 
103 M1 cm1(16). One mMTTR samples were prepared in the same buffer
Wild-Type TTR Amyloid Structure 2487and all samples were dialyzed overnight together at room temperature in the
same buffer. Measurements were obtained using MicroCal iTC200 (Piscat-
away, NJ) and data were analyzed using Origin version 7. Raw data were
corrected by subtraction of controls without protein.Fluorescent ANS competition
L-Thyroxine sodium salt (Sigma) was dissolved in ethanol to make a 590
mM stock solution. 1,8-anilinonaphthalene sulfonate (ANS) (Sigma) was
dissolved in dimethyl sulfoxide and the 100 mM stock concentration was
determined using absorbance at 350 nm and an extinction coefficient of
4.95  103 M1 cm1(16). A fivefold molar excess of ANS was added to
1 mMTTR samples or bovine serum albumin for 20 min before T4 addition.
T4 was then mixed and samples were incubated for 45 min at room temper-
ature before analysis in a PTI spectrophotometer using a 1 ml cuvette.
Emission spectra were collected from 390 to 590 nm using 375 nm excita-
tion. The area under the peak from 456 to 476 nm was integrated and the
mean with standard deviation was plotted for five independent experiments.FIGURE 2 TTR amyloid is more protease sensitive than native TTR. (A)
Electrophoresis of 24-h protease digested 1 mM native TTR at 37C (except
Glu-C at 20C) with lane 1-200 pg Proteinase K, lane 2-20 ng Proteinase K,
lane 3-2 ng trypsin, lane 4-2 ng chymotrypsin, lane 5-20 ng Glu-C, lane 6
undigested TTR, and M-SeeBlue Plus 2 prestained marker. (B) 1 mM TTR
amyloid digested with lane 1 undigested TTR amyloid, lane 2-20 ng
Proteinase K, lane 3-2 ng Proteinase K, lane 4-200 pg Proteinase K, lane
5-200 ng trypsin, lane 6-20 ng trypsin, lane 7-2 ng trypsin, lane 8-200 ng
chymotrypsin, lane 9-20 ng chymotrypsin, lane 10-2 ng chymotrypsin,
lane 11-200 pg Glu-C, lane 12-20 ng Glu-C, lane 13-2 ng Glu-C, and
M-SeeBlue Plus 2 marker. (C) Electron microscopy of TTR amyloid
stained with 1% phosphotungstic acid pH 4.3. (D) Electron microscopy
of 200 ng Proteinase K digested TTR amyloid stained with 1% phospho-
tungstic acid pH 4.3.RESULTS
TTR amyloid core does not include
the native B strand
Using the common acid-induced TTR amyloid fibril forma-
tion procedure (17–19), we generated long amyloid fibrils
up to 1.5 mm in length (see Fig. 2 C and Fig. S1 in the Sup-
porting Material) with significant Thioflavin T binding
(Fig. S2). To determine the amino acid composition of the
amyloid core, we used several different proteases including;
Proteinase K, trypsin, chymotrypsin, and Glu-C. These were
selected as they each cleave after different amino acids and
offer an unbiased array of peptide fragments that should
represent the amyloid core. Native TTR is known to be
very sodium dodecyl sulfate and Proteinase K resistant
(20). However, we found the amyloid to be more sensitive
to protease digestion than the native state (Fig. 2). The
increased sensitivity to protease may imply that part of the
TTR molecule is less ordered in the amyloid state than
in the native state. Following digestion of TTR amyloid
with the highest amount of Proteinase K used (20 ng) fibrils
were still visible using electron microscopy, but were very
clumpy compared to untreated TTR amyloid fibrils (Fig. 2
D). These fibrils should contain the amyloid core peptides
(lane 4, Fig. 2 B; Table 1). Using mass spectrometry to
analyze the protease-treated TTR amyloid samples, we
observed that the first 35 amino acids found within the A
and B strands of the native TTR structure were not observed
in protease-resistant fragments (Table 1), indicating that
these amino acids are outside the amyloid core, and thus
easily digested by the proteases. In contrast, residues in
the other strands were found in protease-resistant fragments,
including the short D strand. The most common core
fragments among all the proteases extended from residue
50 to the C-terminal end of the protein or from around
residue 50 to residue 128 with loss of the His6 tag (Table
1). Representative mass spectra of digested and undigested
TTR amyloid are shown in Fig. S3. These results suggestan alternative configuration of the amyloid core that may
exclude the B strands and result from the stacking of the
D and E strands linked by the F strand to the stacked G
and H strands. This alternative protease-resistant configura-
tion is different from the previously proposed amyloid struc-
ture of mutant TTR, which retains the stacking of BEF and
AGH strands as described previously.NMR analysis rules out an in-register parallel
architecture
PITHIRDS-CT measurements of 13C-13C dipole-dipole
couplings (14) among labeled carbonyl sites in 1-13C-Ile-
TTR, 1-13C-Phe-TTR, and 1-13C-Tyr-TTR samples were
performed as a measure of distances among labeled sites
in native TTR and in TTR fibrils. Each preparation was al-
lowed to form amyloid fibrils for at least six months. 1D
solid-state 13C NMR spectra (Fig. S4) showed carbonylBiophysical Journal 101(10) 2485–2492
TABLE 1 Mass spectrometry results for 1 mM TTR digestions
LC-MS major species TTR peptide Calculated mass Range Number of protected sites
Proteinase-K 9590 50–134 9591.528 D strand to end 48
200 pg 47–132 9589.550 D strand to end 49
35–120 9590.528 C strand to H strand 49
9357 44–128 9356.357 Mid C strand to H strand 48
9353.7 51–133 9353.281 D strand to end 47
8579.5 60–134 8580.470 E strand to G strand 43
6917.2 73–133 6917.655 End E strand to end 32
4155.5 86–128 4156.600 F strand to end 28
Trypsin 9590.7 50–134 9591.528 D strand to end 6
20 ng 6139.5 50–104 6140.709 D strand to start G strand 3
2516.5 105–127 2517.884 G strand to H strand None
3141 50–77 3142.397 D strand to helix start 1
Chymotrypsin 9933.9 46–134 9934.911 Mid C strand to end 9
20 ng 6802 46–106 6803.450 Mid C strand to start G strand 6
4799 1–45 4800.566 Start to mid C strand 1
Glu-C 9273.4 53–134 9274.229 D strand to end 9
200 ng 8999.7 56–134 9000.983 E strand to end 8
8450.3 53–128 8451.382 D strand to H strand 8
8177.3 56–128 8178.137 E strand to H strand 7
3789.9 20–55 3789.156 B strand to D strand 2
3514.6 20–52 3515.910 B strand to C strand 1
Native TTR 14054 5–132 14055.705 A sheet to end
Proteinase-K 13896 7–132 13897.548 A sheet to end
20 ng 8305 60–132 8306.189 E strand to end
37–111 8306.094 C strand to G strand
Number of protected sites is number of residues predicted to be the sites of cleavage by the indicated protease that were not cleaved.
2488 Bateman et al.chemical shifts (compared to average random coil values
(21)) consistent with the labeled residues being in b-sheet
structure (Table 2).
PITHIRDS-CT data for native TTR and TTR fibrils are
shown in Fig. 3. None of the PITHIRDS-CT measurements
on TTR fibrils show the relatively rapid signal decay (on the
30 ms timescale) observed in previous measurements on
amyloid fibrils that have parallel in-register b-sheet struc-
tures (12,22,23). Therefore, TTR fibrils do not have
a parallel in-register b-sheet structure. This is consistent









Ile-1-13C native dry 174.65 0.2 0.27 174.7
172.35 0.2 0.73
Ile-1-13C amyloid dry 172.55 0.2
Ile-1-13C amyloid wet 172.45 0.2
Phe-1-13C native 172.35 0.2 174.1
Phe-1-13C amyloid dry 172.35 0.2
Phe-1-13C amyloid wet 172.35 0.2
Tyr-1-13C native dry 173.45 0.2 0.73 174.2
171.95 0.2 0.27
Tyr-1-13C amyloid 172.85 0.2
Ratio of integrated carbonyl peak intensities for wet amyloid samples
divided by dry samples was 0.72 for Phe-1-13C and 0.78 for Ile-1-13C
labeled samples. Deconvolution of the carbonyl peaks for native Tyr-
1-13C and Ile-1-13C samples showed two peaks as listed.
Biophysical Journal 101(10) 2485–2492also be consistent with other models, including the new
model proposed in this work.
Simulations of PITHIRDS-CT experiments on native
TTR, using distances among 1-13C-labeled sites in one
dimer from the crystal structure of a WT TTR dimer
(PDB entry 1F41), predict no signal decay for native
1-13C-Ile-TTR, a decay of the total carbonyl NMR signal
to ~80% by 40 ms for native 1-13C-Tyr-TTR, and a decay
to ~56% for native 1-13C-Phe-TTR (Fig. 3 and Fig. S5).
The experimental PITHIRDS-CT curves for native TTR
samples are in good agreement with these simulations,
except that a weak decay is observed for 1-13C-Ile-TTR,
possibly due to dipole-dipole couplings between dimers
that are not included in the simulations.
Experimental PITHIRDS-CT curves for TTR fibrils are
similar to, but not identical to the curves for native TTR
(Fig. 3). In particular, data for 1-13C-Phe-TTR decay more
slowly in the amyloid form, whereas data for 1-13C-Ile-
TTR decay more rapidly in the hydrated amyloid form.
The difference between PITHIRDS-CT decays for dry and
hydrated 1-13C-Ile-TTR fibrils may be due to the disappear-
ance of signal contributions from certain Ile sites that
become mobile upon hydration. These observations suggest
rearrangements of the b-sheet structure upon conversion of
native TTR to the amyloid form, but the precise nature of
the rearrangements cannot be determined from these data.
The BEF model proposed in earlier work, see Fig. 5 A,
does not predict a reduction in Ile-Ile distances, and there-
fore may not be fully consistent with the PITHIRDS-CT
FIGURE 3 Solid-state NMR measurements of 13C-13C dipole-dipole
couplings on native TTR and TTR amyloid samples, using the PITH-
IRDS-CT technique. Blue triangle curves are for labeled native TTR dry
samples, green squares represent labeled TTR amyloid dry samples, and
red diamonds represent labeled TTR amyloid wet samples. Indicated in
solid black line is the total modeled decay for native TTR using PDB entry
1F41 (7). (A) Data for 1-13C-Ile-TTR show the expected slow decay for the
native TTR but a more rapid decay in the amyloid state. (B and C) Data for
1-13C-Phe-TTR and 1-13C-Tyr-TTR are similar in the native and amyloid
states. Simulated PITHIRDS-CT curve for a linear chain of 13C nuclei
with 5 A˚ spacings shows the relatively rapid decay expected with an
in-register parallel b-sheet structure.
Wild-Type TTR Amyloid Structure 2489data for 1-13C-Ile TTR fibrils. However, couplings between
13C labels in different fibrils within a fibril bundle (not de-
picted in Fig. 5 A) could conceivably produce the experi-
mentally observed PITHIRDS-CT curve. The alternative
model proposed in this work is consistent with the PITH-
IRDS-CT data, but not uniquely so.FIGURE 4 Absence of thyroxine binding to TTR amyloid. Isothermal
calorimetry was used to find direct association of T4 with (A) native
TTR, but not with (B) TTR amyloid. (C) The mean of five independent
ANS T4 competition experiments are plotted using the standard deviation
for the error bars with circle bovine serum albumin, triangle native TTR,
and square for TTR amyloid. TTR amyloid binds an order of magnitude
less ANS than native TTR, and this ANS is not competed off with T4.No T4 binding by the TTR amyloid fibrils
To further address the loss of native conformation within
the TTR amyloid we tested T4 binding directly with
isothermal calorimetry, and indirectly using the common
ANS competition (16). With isothermal calorimetry we
observed the expected association of T4 with native TTR(Fig. 4 A). We calculated an association constant of 1.2 
108 M1, which is in close agreement with the previously
published value of 1.0  108 M1 (16,24). However, we
did not observe association of T4 with TTR amyloid fibrils
(Fig. 4 B). Interestingly, using the indirect competition
method to monitor T4 binding to TTR, we not only observed
the lack of T4 competition but also an order of magnitude
less ANS binding (Fig. 4 C). This may indicate that ANS
is only interacting nonspecifically with exposed hydro-
phobic regions on the TTR amyloid. The native TTR
displayed the expected ANS binding and T4 competition
(Fig. 4 C).DISCUSSION
The full structure of TTR amyloid has yet to be determined.
Our protease digestion results offer interesting insight into
the core of the TTR amyloid fibrils. We find that the residues
from the D strand to the H strand are included in the amyloid
core. This result correlates directly with previous reports
using antigenic mapping of transthyretin amyloid formed
in vivo (25,26), assuming that antibodies react with exposed
antigens, and not with buried sites. Antiserum to TTRBiophysical Journal 101(10) 2485–2492
FIGURE 5 Plausible model for the TTR amyloid. (A) A representation of
the previously suggested TTR amyloid model with strands B, E, and F
(front) comprising one sheet and strands A, G, and H (back) comprising
the other sheet of the amyloid core (10). The C and D strands have been
excluded for clarity. (B) Our proposed TTR amyloid model based on
protease digestion and solid-state NMR spectroscopy results. We have
excluded the N-terminal region up to residue 50 for clarity. We suggest
that the D strand and part of the D loop interact with the E strand, while
the former F strand and helix becomes the linker to the sheet composed
of the interacting G and H strands. Isoleucine residues (red) and phenylal-
anine residues (green) are labeled. This figure was generated using PDB
entry 1F41 (7) and the program Swiss PdbViewer version 4.
2490 Bateman et al.residues 24–35 (within B strand) reacted with both amyloid
and native TTR (25). Antiserum against residues 110–119
(part of the H strand) was found to react less with amyloid
than with native TTR, but antiserum generated to residues
115–124 (H strand) was found to react more with amyloid
indicating possible exposure of the C-terminus in the
amyloid (25). Interestingly, antiserum against residues 50–
60 (D strand) and 90–100 (F strand) reacted less with puri-
fied TTR amyloid than with native, suggesting these regions
are in the core (25). In a similar study antiserum generated
to residues 41–50 (C strand) immunohistochemically
labeled TTR amyloid but not native TTR within sections
of tissue samples (although antibody to TTR75-84 reacted
with both) (26). The 41–50 antiserum was also found to
react with WT TTR amyloid and Y114C amyloid tissue
sections (26). These results taken together suggest that the
TTR amyloid core contains from the D strand to near the
C-terminal end of the protein and not the B strand.
Most pathologic amyloids have a parallel in-register
b-sheet structure, including human Ab, a-synuclein, tau,
amylin, b2 microglobulin, and the yeast prion amyloids of
Ure2p, Sup35p, and Rnq1p (12,22,23,27–31). Amyloids
shown not to have the parallel in-register architecture
include the functional amyloids Pmel 17, involved in verte-
brate melanin biogenesis, curli (CsgA) of Escherichia coli
involved in adhesion and biofilm formation, and the
[Het-s] functional prion of Podospora anserina (32–34).
An in-register parallel structure would result in a distance
of 4.8 A˚ between 13C labels in our TTR amyloid samples,
which would produce relatively rapid signal decay in
PITHIRDS-CT measurements. The results in Fig. 3 rule
out an in-register b-sheet structure for TTR fibrils, as signal
decays are much slower than expected for 4.8 A˚ 13C-13C
spacings, and no detectable components showed rapid
decay. Taken together, our data indicate that residues
26, 33, 44, 64, 68, 69, 73, 78, 84, 87, 95, 105, 107, 114,
and 116 are not in-register.
PITHIRDS-CT data for 1-13C-Ile TTR fibrils in Fig. 3 A
indicate 13C-13C distances of ~7 A˚ (which would produce
a signal decay to ~75% in 30 ms, according to simulations).
Such distances among Ile carbonyls can be achieved with
the schematic structural model in Fig. 5 B. Although this
model is by no means uniquely determined by the PITH-
IRDS-CT data, it is consistent with both the PITHIRDS-
CT data and the protease digestion data. The model in
Fig. 5 B pairs two E strands and two G strands as the edge
strands of the sheets, bringing Ile-68 (start E strand) and
Ile-73 (end of E strand) close together in paired E strands,
and Ile-107 (center of G strand) close in paired G strands.
The previously proposed TTR amyloid model (Fig. 5 A),
assumes a greater conservation of native TTR structure,
with the amyloid core composed of the B, E, and F strands
(10). Using cysteine mutations and electron spin labels,
Serag et al. were only able to obtain seven mutants that
could form amyloid fibrils. Serag et al. present electronBiophysical Journal 101(10) 2485–2492paramagnetic resonance data for spin labels located at sites
29, 31, 33, 40, and 46, which are primarily centered on the B
strand (29, 31, and 33) and C strand (40 and 46) (10). It is
possible that only these modified TTRs formed amyloid
fibrils because these regions are outside the amyloid core,
in accord with our protease digestion results and previously
shown exposed TTR amyloid epitopes (25,26). Further-
more, multiple mass spectrometric analyses of the TTR iso-
lated from tissue deposits have found C-terminal fragments
that start on and around residue 46 (4,35,36). In our model
(Fig. 5 B) the N-terminal region is outside the core of the
amyloid fibril and more susceptible to degradation, thus
accounting for these observed fragments. Alternatively,
the previous model may simply represent a distinct amyloid
form from that in our experiments.
Wild-Type TTR Amyloid Structure 2491Interestingly, recent antibody and mass spectroscopic
studies of amyloid from patients suffering from SSA and
FAP have found distinct structural patterns (37–39). Most
of those with the mutant V30M (FAP) have fibrils composed
of full-length TTR, denoted fibril type B (38), whereas indi-
viduals with SSA with the WT TTR sequence, and a
minority of FAP patients, have fibrils composed mainly of
residues 50–127, the C-terminal fragment, denoted fibril
type A (37–39). Many earlier structural studies of TTR
amyloid used mutant forms, mainly the V30M mutation
(8,9), and may represent fibril type B, whereas we examined
amyloid of WT TTR, representing fibril type A, thus
explaining why we arrive at different models (Fig. 5). An
early analysis of clinical material from a V122I TTR patient
also showed cleavage after residue 48 (40).
Cardoso et al. (41) determined the mass-per-length (MPL)
for amyloid fibrils formed from both WT TTR and L55P
mutant protein. Interestingly, they report two populations
for WT TTR, with MPL values of 9.5 and 14 kDa/nm,
whereas the L55P mutation had a major population of
13.7 kDa/nm (41). Ourmodel (Fig. 5B) uses this information,
and is constructed to give an MPL value of ~14 kDa/nm
(138 kDa molecular mass divided by twice the 0.48 nm
b-strand spacing in a cross-b-fibril structure), which corre-
lates with the results of Cardoso et al. The model of Serag
et al. (10) predicts anMPL value consistent with the observed
9.5 kDa/nmpopulation.AlthoughCordoso et al. (41) interpret
themultipleMPL values as due to different numbers of proto-
filaments comprising each fibril, we suggest that the twomain
values for WT TTR fibrils may be due to the differing
numbers of b-strands per monomer along the fibril long axis
in two distinct fibril structures: two b-strands per monomer
for our TTR fibrils and three for those studied by Serag et al.
T4 binds TTRwithin the inner channel parallel to the crys-
tallographic twofold axis along contacts in the A, G, and H
strands (42–44). Although two T4 molecules can bind the
TTR tetramer, there is negative cooperativity between the
sites leading to one major hormone binding site (16,24,42).
Furthermore, it has been shown recently that Glu-54
(D strand) is not crucial for T4 binding, as a Glu-54-Gly
mutant was found to have similar dissociation constant as
WT and displayed higher association rate (45). For native
TTR we obtained an association constant similar to that
previously published (16,24), however we did not observe
T4 binding to TTR amyloid. If the amyloid state maintained
a near native conformation, then one might expect some T4
binding. It is not uncommon for the amyloid state of a protein
to retain a native state activity. For example, the amyloid
URE3 has been shown to maintain the same peroxidase
activity as the native Ure2 protein (46). Similarly, the
SOD1 aggregate has been shown to have higher activity
than the native protein (47). TTR amyloid does not maintain
its T4 binding, and displays a dramatic reduction in ANS
association, thus the amyloid conformation must be signifi-
cantly different from the native state.Taken together, our results suggest that the TTR amyloid
conformation is significantly different than the native state
and offers a different model for the arrangement of the
b-strands within the amyloid structure.SUPPORTING MATERIAL
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